Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Apyx Medical (APYX) Cost of Revenue (2016 - 2026)

Apyx Medical filings provide 15 years of Cost of Revenue readings, the most recent being $7.2 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 36.27% to $7.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.8 million, a 5.65% increase, with the full-year FY2025 number at $19.8 million, up 5.65% from a year prior.
  • Cost of Revenue hit $7.2 million in Q4 2025 for Apyx Medical, up from $4.6 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $7.2 million in Q4 2025 to a low of $2.8 million in Q1 2021.
  • Median Cost of Revenue over the past 5 years was $4.3 million (2023), compared with a mean of $4.4 million.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 69.36% in 2021 and later fell 12.34% in 2025.
  • Apyx Medical's Cost of Revenue stood at $4.7 million in 2021, then fell by 6.48% to $4.4 million in 2022, then skyrocketed by 31.19% to $5.7 million in 2023, then fell by 8.29% to $5.3 million in 2024, then soared by 36.27% to $7.2 million in 2025.
  • The last three reported values for Cost of Revenue were $7.2 million (Q4 2025), $4.6 million (Q3 2025), and $4.3 million (Q2 2025) per Business Quant data.